Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-02-03
2008-08-12
Romeo, David S (Department: 1647)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C424S426000, C424S486000, C424S488000, C514S801000, C514S944000, C530S350000, C530S356000
Reexamination Certificate
active
07410947
ABSTRACT:
Disclosed herein are improved osteogenic devices and methods of use thereof for repair of bone and cartilage defects. The devices and methods promote accelerated formation of repair tissue with enhanced stability using less osteogenic protein than devices in the art. Defects susceptible to repair with the instant invention include, but are not limited to: critical size defects, non-critical size defects, non-union fractures, fractures, osteochondral defects, subchondral defects, and defects resulting from degenerative diseases such as osteochondritis dessicans.
REFERENCES:
patent: 4353982 (1982-10-01), Gomez et al.
patent: 4968590 (1990-11-01), Kuberasampath et al.
patent: 4975526 (1990-12-01), Kuberasampath et al.
patent: 5011691 (1991-04-01), Oppermann et al.
patent: 5013649 (1991-05-01), Wang et al.
patent: 5073373 (1991-12-01), O'Leary et al.
patent: 5171574 (1992-12-01), Kuberasampath et al.
patent: 5266683 (1993-11-01), Oppermann et al.
patent: 5354557 (1994-10-01), Oppermann et al.
patent: 5366964 (1994-11-01), Lindstrom et al.
patent: 5385887 (1995-01-01), Yim et al.
patent: 5422340 (1995-06-01), Ammann et al.
patent: 5457093 (1995-10-01), Cini et al.
patent: 5468845 (1995-11-01), Oppermann et al.
patent: 5520923 (1996-05-01), Tjia et al.
patent: 5597897 (1997-01-01), Ron et al.
patent: 5645591 (1997-07-01), Kuberasampath et al.
patent: 5674292 (1997-10-01), Tucker et al.
patent: 5674844 (1997-10-01), Kuberasampath et al.
patent: 6232458 (2001-05-01), Weiss et al.
patent: 0 723 013 (1996-07-01), None
patent: WO 90/11366 (1990-10-01), None
patent: WO 91/18098 (1991-11-01), None
patent: WO 91/18558 (1991-12-01), None
patent: WO 94/15653 (1994-07-01), None
patent: WO 94/20133 (1994-09-01), None
patent: WO 95/16035 (1995-06-01), None
patent: WO 95/24210 (1995-09-01), None
patent: WO 95/25546 (1995-09-01), None
patent: WO 96/09078 (1996-03-01), None
patent: WO 96/39169 (1996-12-01), None
patent: WO 96/39170 (1996-12-01), None
patent: WO 96/40297 (1996-12-01), None
Alberts et al., “Molecular Biology of the Cell,” (Garland Publishing, Inc., New York), pp. 692-693, 705 (1983).
Arnaud et al., “Potentiation of transforming growth factor (TGFβ 1) by natural coral and fibrin in a rabbit cranioplasty model,” Calcif Tissue Int. 54(6):493-8 (1994).
Beck et al., “TGF-β1 Induces Bone Closure of Skull Defects,” Journal of Bone and Mineral Research, 6(11):1257-65 (1991).
Beck et al., “The Single Application of TGF-β1 Induces Closure of Skull Defects,” Journal of Bone and Mineral Research, 6(suppl 1):155 (1991).
Bowie et al., “Deciphering the Message in Protein Sequences: Tolerance to Amino Acid Substitutions”, Science, 247 (4948):1306-10 (1990).
Bulletin VC-543C, “Rheology of Aqualon® Water-Soluble Polymers in Solution,” Hercules Incorporated, Aqualon Division, Hercules Plaza, 1313 North Market Street, Wilingtohn, DE 19897-0001, 2001.
Cao et al., “Water Vapour-Treated Hydroxyapatite Coatings After Plasma Spraying and Their Characteristics,” Biomaterials, 17(4):419-424 (1996).
Carroll, “Patient Status and Contrast Agents” in Fuchs's Radiographic Exposure, Processing and Quality Control, 5th ed. (Charles C. Thomas Publisher, Illinois), pp. 151-154 (1993).
Cook et al., “Recombinant Human Bone Morphogenetic Protein-7 Induces Healing in a Canine Long-Bone Segmental Defect Model,” Clinical Orthopaedics and Related Research, 301:302-312 (1994).
Cook et al., “The Effect of Recombinant Human Osteogenic Protein-1 on Healing of Large Segmental Bone Defects,” The Journal of Bone and Joint Surgery, 76-A(6):827-838 (1994).
Dayhoff et al., “A Model of Evolutionary Change in Proteins,” Chapter 22 Atlas of Protein Sequence and Structure, 5(suppl. 3):345-52 (1978).
Doll et al., “The Osteogenic Potential of Two Composite Graft Systems Using Osteogenin,” Journal of Periodontology 61(12):745-50 (1990).
Ehrlich and McCloskey, “Contrast Media and Special Imaging Techniques” in Patient Care in Radiography, 4th ed. (Mosby, St. Louis), pp. 211-254 (1993).
FMC Corp., Technical Bulletin RC-16, pp. 1-8 (1986).
Handbook of Pharmaceutical Excipients, 2nd ed., A Wade and P.J. Weller (eds), American Pharmaceutical Association, Washington, DC, Jan. 1994, p. xiii.
Johnson et al., “Porous Ceramics as Bone Graft Substitutes in Long Bone Defects: A Biomechanical, Histological, and Radiographic Analysis,” Journal of Orthopaedic Research, 14:351-369 (1996).
Kenley et al., “Osseous Regeneration in the Rat Calvarium Using Novel Delivery Systems for Recombinant Human Bone Morphogenetic Protein-2 (rhBMP-2),” Journal of Biomedical Materials Research, 28:1139-1147 (1994).
LeGeros and Daculsi, “In Vivo Transformation of Biphasic Calcium Phosphate Ceramics: Ultrastructural and Physicochemical Characterizations,” in CRC Handbook of Bioactive Ceramics (CRC Press), vol. II, pp. 17-28 (1990).
LeGeros, “Calcium Phosphate Materials in Restorative Dentistry: A Review,” Advances in Dental Research, 2(1):164-180 (1988).
Ogawa et al., “Bovine Bone Activin Enhances Bone Morphogenetic Protein-induced Ectopic Bone Formation”, J. Biol. Chem., 267(20):14233-7 (1992).
Piatelli et al., “Clinical and Histologic Aspects of Biphasic Calcium Phosphate Ceramic (BCP) Used in Connection With Implant Placement,” Biomaterials, 17(18):1767-70 (1996).
Reddi, A.H., “Symbiosis of Biotechnology and Biomaterials: Applications in Tissue Engineering of Bone and Cartilage,” Journal of Cellular Biochemistry, 56(2):192-5 (1994).
Sampath and Reddi, “Homology of Bone-inductive Proteins from Human, Monkey, Bovine, and Rat Extracellular Matrix,” Proc. Natl. Acad. Sci. USA, 80:6591-6595 (1983).
Sato et al., “Bone Morphogenesis of Rabbit Bone Morphogenetic Protein-bound Hydroxyapatite-fibrin Composite.” Clin. Orthop. and Related Research, 263:254-62 (1991).
Schmitz and Hollinger, “The Critical Size Defect as an Experimental Model for Craniomandibulofacial Nonunions,” Clinical Orthopaedics and Related Research, 205:299-308 (1986).
Shapiro, “Cell Origin and Differentiation in the Repair of Full-Thickness Defects of Articular Cartilage,” The Journal of Bone and Joint Surgery 75-A(4):532-553 (1993).
Snopek, “Contrast Media” in Fundamentals of Special Radiographic Procedures, 3rd ed. (Harcourt, Pennsylvania), pp. 66-76 (1992).
Turco, S.J., “Intravenous Admixtures,” Chapter 95, in Remington's Pharmaceutical Sciences, 18th Ed. (Mack Pub. Co., Easton, PA), pp. 1570 (1990).
Vukicevic et al., “Extracellular Matrix and Bone Morphogenetic Proteins in Cartilage and Bone Development and Repair,” Advances in Molecular and Cell Biology, 6:207-224 (1993).
Rueger David C.
Tucker Marjorie M.
Haley Jr. James F.
Mangasarian Karen
Romeo David S
Ropes & Gray LLP
Stryker Corporation
LandOfFree
Osteogenic devices and methods of use thereof for repair of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Osteogenic devices and methods of use thereof for repair of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Osteogenic devices and methods of use thereof for repair of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4012053